Arjo AB (publ)

Healthcare US ARRJF

NoneUSD
-(-%)

Last update at 2025-05-01T13:39:45.140224Z

Day Range

--
LowHigh

52 Week Range

3.074.85
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap864.00M
  • VolumeNone
  • P/E Ratio18.06
  • Dividend Yield2.69%
  • EBITDA1622.00M
  • Revenue TTM11182.00M
  • Revenue Per Share TTM41.05
  • Gross Profit TTM 4211.00M
  • Diluted EPS TTM0.17

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax 640.00M 597.00M 989.00M 702.00M 542.00M
Minority interest - - - - -
Net income 480.00M 449.00M 742.00M 526.00M 403.00M
Selling general administrative 1462.00M 1329.00M 1222.00M 1258.00M 1223.00M
Selling and marketing expenses 2163.00M 1969.00M 1753.00M 1796.00M 1797.00M
Gross profit 4736.00M 4211.00M 4209.00M 4126.00M 3886.00M
Reconciled depreciation 1146.00M 1077.00M 956.00M 973.00M 1004.00M
Ebit 903.00M 622.00M 1076.00M 844.00M 731.00M
Ebitda 1961.00M 1699.00M 2032.00M 1817.00M 1735.00M
Depreciation and amortization 1058.00M 1077.00M 956.00M 973.00M 1004.00M
Non operating income net other - - - - -
Operating income 884.00M 691.00M 1077.00M 866.00M 671.00M
Other operating expenses 10096.00M 9205.00M 7946.00M 8135.00M 8200.00M
Interest expense 263.00M 115.00M 87.00M 145.00M 136.00M
Tax provision 129.00M 149.00M 247.00M 175.00M 139.00M
Interest income 28.00M 16.00M 4.00M 5.00M 8.00M
Net interest income -231.00000M -119.00000M -94.00000M -140.00000M -128.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 160.00M 149.00M 247.00M 175.00M 139.00M
Total revenue 10980.00M 9979.00M 9070.00M 9078.00M 8925.00M
Total operating expenses 3852.00M 3437.00M 3085.00M 3183.00M 3161.00M
Cost of revenue 6244.00M 5768.00M 4861.00M 4952.00M 5039.00M
Total other income expense net -244.00000M -94.00000M -88.00000M -164.00000M -129.00000M
Discontinued operations - - - - -
Net income from continuing ops 388.00M 447.00M 742.00M 526.00M 403.00M
Net income applicable to common shares - 447.00M 742.00M 526.00M 403.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 15444.00M 16167.00M 14612.00M 13858.00M 14422.00M
Intangible assets 1040.00M 1718.00M 1694.00M 1673.00M 1660.00M
Earning assets - - - - -
Other current assets 2193.00M - 32.00M 27.00M 16.00M
Total liab 7862.00M 8543.00M 7727.00M 8228.00M 8508.00M
Total stockholder equity 7582.00M 7624.00M 6885.00M 5630.00M 5914.00M
Deferred long term liab - - 468.00M 350.00M 341.00M
Other current liab 1396.00M 1354.00M 1372.00M 4414.00M 1095.00M
Common stock 91.00M 91.00M 91.00M 91.00M 91.00M
Capital stock 91.00M 91.00M 91.00M 91.00M 91.00M
Retained earnings 6176.00M 6138.00M 6028.00M 5367.00M 4908.00M
Other liab - 1614.00M 257.00M 157.00M 167.00M
Good will 5637.00M 5673.00M 5405.00M 5161.00M 5412.00M
Other assets 2.00M - 1.00M 664.00M -1.00000M
Cash 923.00M 949.00M 757.00M 972.00M 662.00M
Cash and equivalents - - - - -
Total current liabilities 4396.00M 4622.00M 6491.00M 5214.00M 5526.00M
Current deferred revenue 1257.00M 1142.00M 1156.00M 4121.00M 870.00M
Net debt 4563.00M 5364.00M 4696.00M 126.00M 5902.00M
Short term debt 2299.00M 2681.00M 4505.00M 296.00M 3888.00M
Short long term debt 1934.00M 2322.00M 4177.00M - 3575.00M
Short long term debt total 5486.00M 6313.00M 5453.00M 1098.00M 6564.00M
Other stockholder equity 1315.00M 1395.00M 766.00M 172.00M 915.00M
Property plant equipment - 2909.00M 2555.00M 2326.00M 2450.00M
Total current assets 4417.00M 5030.00M 4174.00M 4130.00M 4400.00M
Long term investments - - - - 501.00M
Net tangible assets - 233.00M 254.00M -854.00000M -817.00000M
Short term investments -76.00000M - - - -
Net receivables 2000.00M 1708.00M 1913.00M 2012.00M 2488.00M
Long term debt 2391.00M 2823.00M 118.00M - 1791.00M
Inventory 1301.00M 1674.00M 1369.00M 1039.00M 1144.00M
Accounts payable 612.00M 587.00M 614.00M 504.00M 543.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1315.00M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1300.00M 523.00M 526.00M 312.00M 169.00M
Deferred long term asset charges - - - - -
Non current assets total 11025.00M 11137.00M 10437.00M 9728.00M 10023.00M
Capital lease obligations 1161.00M 1168.00M 1158.00M 1098.00M 1198.00M
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -789.00000M -902.00000M -695.00000M -139.00000M -78.00000M
Change to liabilities - 0.00000M 0.00000M 0.00000M 0.00000M
Total cashflows from investing activities - -902.00000M -695.00000M -972.00000M -801.00000M
Net borrowings - 204.00M -1196.00000M -544.00000M -673.00000M
Total cash from financing activities -1427.00000M 136.00M -1277.00000M -954.00000M -762.00000M
Change to operating activities - -270.00000M 21.00M 438.00M 59.00M
Net income 480.00M 691.00M 1077.00M 866.00M 671.00M
Change in cash -26.00000M 192.00M -215.00000M 310.00M -299.00000M
Begin period cash flow 949.00M 757.00M 972.00M 662.00M 961.00M
End period cash flow 923.00M 949.00M 757.00M 972.00M 662.00M
Total cash from operating activities 2061.00M 915.00M 1734.00M 2267.00M 1252.00M
Issuance of capital stock - - - - -
Depreciation 1062.00M 1077.00M 956.00M 973.00M 1004.00M
Other cashflows from investing activities - -1.00000M -1.00000M -1.00000M -1.00000M
Dividends paid 232.00M 313.00M 232.00M 177.00M 150.00M
Change to inventory 192.00M -165.00000M -232.00000M -30.00000M 38.00M
Change to account receivables 130.00M -76.00000M 135.00M 214.00M -133.00000M
Sale purchase of stock - - - - -
Other cashflows from financing activities -24925.00000M 24196.00M 9763.00M 8005.00M 9381.00M
Change to netincome - -97.00000M 112.00M 149.00M -113.00000M
Capital expenditures 604.00M 900.00M 760.00M 807.00M 758.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 525.00M -511.00000M -76.00000M 622.00M -36.00000M
Stock based compensation - - - - -
Other non cash items -6.00000M -342.00000M -223.00000M -194.00000M -387.00000M
Free cash flow 1457.00M 15.00M 974.00M 1460.00M 494.00M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ARRJF
Arjo AB (publ)
- -% - 18.06 11.31 0.08 1.16 0.90 5.04
MCK
McKesson Corporation
-0.705 0.10% 730.10 17.95 14.53 0.20 5.04 0.22 12.17
COR
Cencora Inc.
0.94 0.32% 295.98 23.39 - - -
CAH
Cardinal Health Inc
1.94 1.21% 162.46 166.11 14.71 0.12 16.07 0.12 19.78
HSIC
Henry Schein Inc
-0.78 1.10% 70.30 24.12 14.04 0.74 2.50 0.95 13.33

Reports Covered

Stock Research & News

Profile

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.

Arjo AB (publ)

Hans Michelsensgatan 10, Malmö, Sweden, 201 20

Key Executives

Name Title Year Born
Mr. Joacim Lindoff CEO, Pres & Director 1973
Mr. Daniel Fäldt Chief Financial Officer 1976
Jonas Cederhage Exec. VP of Product Devel., Supply Chain & Operations 1971
Ms. Ingrid Carlsson Exec. VP of Legal & Bus. Compliance and Board Sec. 1976
Ms. Kornelia Rasmussen Exec. VP of Communication & PR 1977
Mr. Paul Lyon Pres Global Sales & Service 1962
Tobias Kramer Exec. VP of Global Marketing NA
Ms. Marion Gullstrand Exec. VP of HR & Sustainability 1957
Ms. Katarzyna Bobrow Exec. VP of Quality & Regulatory Compliance 1980
Mr. Christian Stentoft Exec. VP & Chief Strategy Officer 1984

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.